The Latest Medical Devices Articles from Streetwise Reports


Medical Device Firm Engages Distributor for Its TransDermal Infusion System

Research Report
  ()
Sensus Healthcare's "needle-free treatment presents a clear competitive advantage in the aesthetic dermatology space," an H.C. Wainwright & Co. report noted. read more >

Robotic Surgical Systems Co.'s Shares Gain 21% on Q3 Earnings and Forward Revenue Outlook

  ()
Stereotaxis Inc. shares traded higher after the company reported Q3/21 financial results and confirmed its FY/21 revenue guidance. The company added that it is sufficiently funded and is on pace towards doubling its system revenue in FY/22. read more >

Robotic Surgical Device Maker's Shares Maneuver Higher on Q3 Earnings

  ()
Shares of robotic performance-guided surgery device maker Asensus Surgical Inc. traded 21% higher after the company reported Q3/21 financial results that included a 215% increase in YoY revenue. read more >

SmileDirectClub Granted Patent for Mobile Oral Care Bus to Serve Remote Regions in the US & UK

  ()
SmileDirectClub Inc. shares traded 15% higher after the company reported that the U.S. Patent & Trademark Office has allowed its new patent for the firm's mobile SmileBus concept whereby its SmileShop on wheels is mobilized to expand access to convenient, affordable oral care in remote areas across the U.S. and the U.K. read more >

Telemedicine Tech Firm Poised to Generate $11 Million of Revenue

  ()
Reliq Health Technologies signs contracts with three new clients for its proprietary remote healthcare delivery and care tracking platform, which has particularly significant implications during the era of the COVID-19 pandemic. read more >

Medical Device Company's Improved Fundamentals Offer Multiple Expansion Potential

Research Report
  ()
ROTH Capital Partners LLC commented in a research report that it is maintaining its "Buy" rating and raising its FY/22 revenue estimates for Dynatronics Corp. to $41 million after the firm pre-announced Q4/21 revenue figures that exceeded prior estimates. read more >

Third Implantation of Device Firm's Total Artificial Heart That 'Could Save Many Patients Who May Die'

Research Report
  ()
An H.C. Wainwright & Co. report noted that Carmat's Aeson implant "could save many patients who may die, due to [a] shortage of donor hearts, while waiting for a heart transplant." read more >

Dermatological Device Company to Acquire Laser System Firm

Research Report
  ()
An H.C. Wainwright report noted that "this deal is an opportunity for STRATA Skin Sciences to substantially increase its long-term, recurring revenue base." read more >

Diagnostics Firm Readies for Pivotal FDA Study of Device That Detects Bacterial Lung Infections

  ()
Promising early results and a new line of equity support Avisa Diagnostic’s drive for IDE approval of its rapid-response breath test for pneumonia, TB, CF, and other lung ailments. read more >

STAAR Shares Burst Higher after Firm Posts 77% Increase in Q2 Net Sales and Raises FY Outlook

  ()
Shares of STAAR Surgical Co. traded 20% higher after the company reported Q2/21 financial results highlighting a 93% YoY increase in net sales of its Implantable Collamer® Lenses. read more >

Coverage Initiated on Company with a 'Genuine Physiological Heart Replacement Therapy'

Research Report
  ()
The investment thesis for the device company Carmat, whose therapy "allows patients to live with almost normal quality of life," is presented in an H.C. Wainwright & Co. report. read more >

Biopharma Partners with NIH to Advance Women's Hormone-Free Contraceptive

Research Report
  ()
A Roth Capital Partners report calls this a "very cost-effective and strategic move" for Daré Bioscience. read more >

Zynex Shares Rise as Firm Notches Significant Q2 Order Growth and Raises EBITDA Outlook

  ()
Zynex Inc. shares traded 10% higher after the electrotherapy medical device maker reported a 247% YoY growth in orders during Q2/21 and raised the range for its EBITDA estimates in the quarter by $1.2 million. read more >

Pulse Bio Shares Beat Higher on Launch of CellFX NPS System in Canada

  ()
Pulse Biosciences shares traded 27% higher after the company announced it secured a $50 million private placement one day after it reported the first CellFX® procedure using its proprietary Nano-Pulse Stimulation technology had been performed in Canada. read more >
Showing Results: 1 to 14 of 14

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts